IQVIA has grown revenue 4.7% a year over three years and 6.7% a year over five, with earnings per share compounding at 13%. Revenue growth, 3-year annual rate: +4.7% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +6.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +13%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 15, FY2011 to FY2025, as filed.

IQVIQVIA

HealthcareUSD

$261.57

$156.6652 weeks$261.57

Is it growing?

Is IQV growing?

IQVIA has grown revenue 4.7% a year over three years and 6.7% a year over five, with earnings per share compounding at 13%.

+4.7%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +6.7%
Revenue growth, 5-year rate · +4.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +13%
Earnings per share, 3-year rate · revenue +4.7% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed